Makoto Takahashi

发表

Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures

Toshiyuki Someya, Norio Ozaki, Katsuyoshi Mizukami, 2010, Schizophrenia Research.

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients

H. Nawa, Yuichiro Watanabe, T. Someya, 2002, Psychiatry Research.

Supportive evidence for reduced expression of GNB1L in schizophrenia.

M. Itokawa, A. Kakita, Hitoshi Takahashi, 2010, Schizophrenia bulletin.

Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia.

M. Itokawa, A. Kakita, M. Yaniv, 2009, Human molecular genetics.

Relationships between Plasma β-Amyloid Peptide 1–42 and Atherosclerotic Risk Factors in Community-Based Older Populations

Y. Fujiwara, S. Shinkai, Makoto Takahashi, 2003, Gerontology.

Brain Cannabinoid CB2 Receptor in Schizophrenia

M. Itokawa, A. Kakita, Hitoshi Takahashi, 2010, Biological Psychiatry.

Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia

Norio Ozaki, Masanari Itokawa, Hitoshi Takahashi, 2010, Neuropsychopharmacology.

Is DSM widely accepted by Japanese clinicians?

T. Someya, Makoto Takahashi, 2001, Psychiatry and clinical neurosciences.

Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography

Y. Yonekura, S. Tsuji, Y. Onishi, 1996, European Journal of Nuclear Medicine.

Sustained brain‐derived neurotrophic factor up‐regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment

E. Castrén, A. Kakita, K. Sakimura, 2006, Journal of neurochemistry.

125I-iomazeniI binding shows stress- and/or diazepam-induced reductions in mouse brain: Supporting data for123I-iomazenil SPECT study of anxiety disorders

I. Odano, M. Ohkubo, Makoto Takahashi, 1997, Annals of nuclear medicine.